Circulation: Arrhythmia and Electrophysiology

JANUARY 29, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:High-power short-duration ablation has shown impressive efficacy and safety for pulmonary vein isolation (PVI); however, initial efficacy results with very high power short-duration ablation were discouraging. or acute reconnection (4% versus 14%;P=0.3)

Electrophysiology 76

Electrophysiology Atrial Fibrillation Pulmonary Ablation 76

HeartRhythm

JANUARY 6, 2025

1 PFA is conventionally used for pulmonary vein isolation (PVI), but interest has arisen in delivering linear lesions to the posterior wall2 and mitral isthmus.3 Pulsed field ablation (PFA) is a novel modality shown to be safe and efficient.1 3 The durability of these lesion sets has not been well evaluated.

Electrophysiology 40

Electrophysiology Bicuspid/Mitral Arrhythmia Pulmonary 40

DAIC

APRIL 18, 2024

Two articles and an accompanying editorial in Heart Rhythm , the official journal of the Heart Rhythm Society, the Cardiac Electrophysiology Society , and the Pediatric & Congenital Electrophysiology Society , published by Elsevier , address the controversy and recommend shortening the blanking period.

Atrial Fibrillation 111

Atrial Fibrillation Ablation Heart Rhythm Article 111

DAIC

JULY 31, 2024

a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, reported it has submitted a 510(k) for approval of its patented Morph DNA Steerable Introducer Sheath. mtaschetta-millane Wed, 07/31/2024 - 07:00 July 31, 2024 — BioCardia, Inc. ,

Myocardial Infarction 99

Myocardial Infarction Technology Angina Pulmonary 99

DAIC

JANUARY 31, 2024

A company statement reported that its PFA System is indicated for the isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, paroxysmal (i.e., The FARAPULSE PFA System is indicated for the isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, paroxysmal (i.e.,

Ablation 111

Ablation Atrial Fibrillation Anatomy Pulmonary 111

Circulation: Arrhythmia and Electrophysiology

MARCH 21, 2025

Circulation: Arrhythmia and Electrophysiology, Ahead of Print.

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Arrhythmia Pulmonary 40

HeartRhythm

AUGUST 27, 2024

Epicardial Marshall bundle (MB) are frequently utilized in left atrial tachycardias (LATs) post atrial fibrillation (AF) ablation with pulmonary vein isolation and substrate modification.

Atrial Fibrillation 40

Atrial Fibrillation Tachycardia Ablation Electrophysiology 40

Journal of Cardiovascular Electrophysiology

JANUARY 11, 2024

In this study, AEPVR (acute epicardial pulmonary vein reconnection) was differentiated in characteristics from endocardial conduction gap in acute PVR (left). We aimed to investigate the prevalence, locations, electrogram characteristics, and ablation parameters related to acute epicardial pulmonary vein reconnection (AEPVR).

Pulmonary 40

Pulmonary Ablation Electrophysiology Article 40

Circulation: Arrhythmia and Electrophysiology

NOVEMBER 3, 2023

Circulation: Arrhythmia and Electrophysiology, Volume 16, Issue 11 , Page e012043, November 1, 2023. BACKGROUND:In patients with persistent atrial fibrillation (PersAF), catheter ablation aiming for pulmonary vein isolation (PVI) is associated with moderate clinical effectiveness.

Atrial Fibrillation 40

Atrial Fibrillation Pulmonary Quality of Life Ablation 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 5, 2023

Abstract Introduction Carina breakthrough (CB) at the right pulmonary vein (RPV) can occur after circumferential pulmonary vein isolation (PVI) due to epicardial bridging or transient tissue edema. High-power short-duration (HPSD) ablation may increase the incidence of RPV CB.

Pulmonary 40

Pulmonary Ablation Atrial Fibrillation Article 40

Journal of Cardiovascular Electrophysiology

FEBRUARY 20, 2025

Methods In this study, blood samples were collected from 16 patients before and 24h after pulmonary vein isolation (PVI) via a novel investigational PFA-based technology.

Biomarkers 40

Biomarkers Pulmonary Technology Ablation 40

HeartRhythm

APRIL 30, 2024

Pulsed-field ablation (PFA) is becoming increasingly relevant in the field of electrophysiology. Besides single-shot PFA devices for pulmonary vein isolation (PVI), point-by-point PFA is also gaining importance due to many possible applications. Data on the use is sparse, especially for atrial tachycardia (AT).

Tachycardia 40

Tachycardia Ablation Electrophysiology Technology 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 20, 2024

ABSTRACT Introduction Pulmonary vein (PV) restenosis develops with reported incidence rates of up to 50%. Balloon angioplasty seems to be the widely preferred treatment of choice. Method and Results A 54-year-old man with long history of atrial fibrillations developed PVS secondary to multiple radiofrequency ablation procedures.

Stents 40

Stents Stent Pulmonary Angioplasty 40

Journal of Cardiovascular Electrophysiology

MARCH 3, 2024

Abstract Introduction Through systematic scientific rigor, the CLOSE guided workflow was developed and has been shown to improve pulmonary vein isolation durability. However, this technique was developed at a time when using power-controlled ablation catheters with conventional power ranges was the norm.

Ablation 40

Ablation Pulmonary Technology Outcomes 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 5, 2024

Abstract Introduction The novel cryoballoon with 28mm or 31mm adjustable diameters, aims to achieve a wide antral pulmonary vein isolation (PVI). We assessed the shapes of the LA and pulmonary veins (PVs) and the distribution of isolated areas (IAs), comparing the results between PAF and non-PAF patients.

Pulmonary 40

Pulmonary Atrial Fibrillation Article 40

DAIC

DECEMBER 29, 2023

Patients in the study will be randomized to undergo pulmonary vein isolation (PVI) and left atrial posterior wall ablation using the FARAPULSE PFA System, or receive AAD treatment, and followed for three years. The randomized AVANT GUARD trial will enroll more than 500 patients diagnosed with persistent AF at up to 75 sites globally.

Atrial Fibrillation 115

Atrial Fibrillation Ablation Atrial Flutter Blood Clot 115

Circulation: Arrhythmia and Electrophysiology

DECEMBER 19, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Pulmonary vein isolation (PVI) alone is less effective in patients with persistent atrial fibrillation (AF) compared with those with paroxysmal AF.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Arrhythmia Pulmonary 40

Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

Backgroundwide antral pulmonary vein isolation (PVI) is effective for treating paroxysmal atrial fibrillation (PAF), although time-demanding. Procedural data and electrophysiology (EP) laboratory times were systematically collected and analyzed.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Laboratory Electrophysiology 52

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Introduction Atrial tachyarrhythmia recurrence during the blanking period (early ATA) after pulmonary vein isolation (PVI) is associated with an increased risk of later recurrence, but its relationship with pulmonary vein reconduction (PVR) is poorly understood.

Pulmonary 40

Pulmonary Atrial Fibrillation Ablation Article 40

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Introduction Although first-pass isolation (FPI) of the pulmonary vein (PV) has been suggested as a marker for PV isolation (PVI) durability, it has not been confirmed. Non-PV atrial fibrillation (AF) triggers were the main target in patients without PV reconnection in the second ablation procedure, but the outcome was unclear.

Atrial Fibrillation 40

Atrial Fibrillation Pulmonary Ablation Outcomes 40

HeartRhythm

MARCH 12, 2024

A 37-year-old woman with biventricular repair for pulmonary atresia and an intact ventricular septum was referred for an electrophysiological study in the context of recurrent atrial arrhythmias with multiple electrical cardioversions. Her clinical tachycardia was easily inducible and had a cycle length (TCL) of 340 ms.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Electrophysiology 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 29, 2024

We aimed to determine the association between LAWT and AF recurrence after pulmonary vein isolation (PVI), as well as to evaluate the relationship between LAWT and LA fibrosis. Although LA wall thickness (LAWT) has emerged as an indicator of structural remodeling, its impact on AF outcomes remains unclear.

Pulmonary 40

Pulmonary Ablation Atrial Fibrillation Outcomes 40

Circulation: Arrhythmia and Electrophysiology

NOVEMBER 29, 2024

Circulation: Arrhythmia and Electrophysiology, Volume 17, Issue 12 , Page e013208, December 1, 2024. BACKGROUND:The pentaspline pulsed field ablation catheter achieves pulmonary vein isolation using 8 stacked, pose-specific applications with rotation. versus 6.12.0 mm;P=0.02).

Ablation 40

Ablation Pulmonary Electrophysiology Arrhythmia 40

Journal of Cardiovascular Electrophysiology

MARCH 6, 2024

This novel cryoballoon with adjustable size and low compliance successfully achieves pulmonary vein isolation to treat paroxysmal atrial fibrillation (PAF), providing more options for patients with PAF. This cryoballoon system was proven to be safe and effective for treatment of patients with drug refractory or drug intolerant PAF.

Pulmonary 40

Pulmonary Atrial Fibrillation Outcomes Document 40

CardiacWire

DECEMBER 17, 2023

PFA systems use electroporation (short electrical pulses) to achieve pulmonary vein isolation. The AFib pulsed field ablation treatment era officially began in the US last week, following the FDA approval of Medtronic’s PulseSelect Pulsed Field Ablation System for the treatment of both paroxysmal and persistent atrial fibrillation.

AFIB 105

AFIB Ablation Atrial Fibrillation Pulmonary 105

Journal of Cardiovascular Electrophysiology

FEBRUARY 8, 2024

Abstract Introduction Pulsed field ablation (PFA) has emerged as an innovative technique for pulmonary vein isolation (PVI). Typically, a transeptal puncture (TSP) with a standard sheath precedes a switch to the larger diameter sheath in the left atrium.

Pulmonary 40

Pulmonary Ablation Atrial Fibrillation Innovation 40

Circulation: Arrhythmia and Electrophysiology

NOVEMBER 23, 2023

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. A contact force–sensing catheter was used to focally deliver PFA/radiofrequency at the pulmonary veins and other predefined sites in the atria. Transmurality was achieved in 95% of targeted sites and 100% at pulmonary veins.

Ablation 40

Ablation Pulmonary Atrial Fibrillation Electrophysiology 40

Journal of Cardiovascular Electrophysiology

JANUARY 28, 2024

Abstract Objective To evaluate the progression of electrophysiological phenomena in atrial fibrillation (AF) and elucidate the association between the left atrial conduction velocity (LACV) and AF recurrence after pulmonary vein isolation.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Pulmonary Bicuspid/Mitral 40

Circulation: Arrhythmia and Electrophysiology

DECEMBER 16, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print.

Ablation 40

Ablation Atrial Fibrillation Electrophysiology Pulmonary 40

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Background The newly introduced nonthermal pulsed field ablation (PFA) is a promising technology to achieve fast pulmonary vein isolation (PVI) with high acute success rates and good safety features. PFA versus VHPSD for PVI.

Ablation 40

Ablation Pulmonary Arrhythmia Atrial Fibrillation 40

Journal of Cardiovascular Electrophysiology

OCTOBER 23, 2023

We used the algorithm to study the effect of pulmonary vein isolation (PVI) on the frequency of focal, planar, and colliding wavefronts in persistent AF. Abstract RETRO-mapping was developed to automate activation mapping of atrial fibrillation (AF).

Atrial Fibrillation 40

Atrial Fibrillation Pulmonary Outcomes 40

Journal of Cardiovascular Electrophysiology

APRIL 10, 2025

Methods and Results A 51-year-old female with paroxysmal atrial fibrillation comorbid bronchial asthma underwent pulmonary vein isolation with PFA using PulseSelect system. During application at the right superior pulmonary vein antrum, repeated oxygen desaturation with upper airway obstruction was observed.

Ablation 45

Ablation Atrial Fibrillation Pulmonary 45

Journal of Cardiovascular Electrophysiology

JANUARY 28, 2024

We aim to determine the clinical and procedural predictors of pulmonary vein FPI. Abstract Introduction During atrial fibrillation ablation (AFA), achievement of first pass isolation (FPI) reflects effective lesion formation and predicts long-term freedom from arrhythmia recurrence.

Ablation 40

Ablation Pulmonary BMI Atrial Fibrillation 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 21, 2023

Abstract Introduction Pulmonary vein isolations (PVI) are being performed using a high-power, short-duration (HPSD) strategy. Procedural were substantially reduced with HPSD ablation with no significant difference in overall complication rates.

Ablation 40

Ablation Pulmonary Atrial Fibrillation Arrhythmia 40

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Introduction Pulmonary vein isolation (PVI) is a pivotal part of ablative therapy for atrial fibrillation (AF). After 12 months of follow-up, there was an 81% freedom of AF in general, which was significantly higher in patients treated with robotic magnetic navigation-guided radiofrequency ablation (RMN-RF).

Atrial Fibrillation 40

Atrial Fibrillation Ablation Pulmonary Article 40

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

We present the long-term outcome of catheter ablation (CA) and electrophysiological characteristics in HIV+ AF patients. During first procedure, all received isolation of pulmonary vein (PV) + posterior wall and superior vena cava.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outcomes Arrhythmia 40

Journal of Cardiovascular Electrophysiology

JANUARY 28, 2024

Methods This study enrolled 233 PeAF patients undergoing pulmonary vein isolation and linear ablation including an MI, roof line, and cavotricuspid isthmus ablation. However, the effect of an initial RF ablation with an adjunctive EIVOM has not been fully investigated.

Atrial Fibrillation 75

Atrial Fibrillation Ablation Bicuspid/Mitral Tachycardia 75